Study Identifies New Role of BioAegis' 'Inflammation Regulator' Gelsolin Relevant for a Range of Inflammatory Diseases
Study Identifies New Role of BioAegis’ ‘Inflammation Regulator’ Gelsolin Relevant for a Range of Inflammatory Diseases April 08, 2021 18:58 ET | Source: BioAegis Therapeutics BioAegis Therapeutics Morristown, New Jersey, UNITED STATES Gelsolin mitigates vascular damage by preventing release of IL-1β microparticles after trauma of high pressure and decompression. Gelsolin is non-immunosuppressive unlike current treatments to quell inflammato...
Steven Cordovano Susan Levinson University Of Maryland School Medicine Bioaegis Therapeutics Inc Aegis Therapeutics Inc Maryland School
Source: globenewswire.com